Bob Silverman

Bob Silverman

Berater bei
The New York City Investment Fund Manager, Inc.
Finance
Consumer Services
Commercial Services

Profil

Bob A. Silverman currently works at The New York City Investment Fund Manager, Inc., as Advisor and C2i Genomics, Inc., as Chief Business Officer from 2023.
Mr. Silverman also formerly worked at Biohealth Innovation, Inc., as Director, Roche Holding AG, as Venture Capital Lead from 2012 to 2020, Pennie & Edmonds LLP, as Associate, Alloy Therapeutics LLC, as Executive Partner & Chief Business Officer from 2019 to 2021, and Rejuveron Life Sciences AG, as Chief Business Officer from 2021 to 2022.
Mr. Silverman received his undergraduate degree from Franklin & Marshall College and graduate degree from Boston University School of Law.

Aktive Positionen von Bob Silverman

UnternehmenPositionBeginn
Berater -
Corporate Officer/Principal 01.01.2023

Ehemalige bekannte Positionen von Bob Silverman

UnternehmenPositionEnde
Corporate Officer/Principal 01.12.2022
Corporate Officer/Principal 01.07.2021
ROCHE HOLDING AG General Counsel 31.12.2003
Corporate Officer/Principal 31.12.1993
Direktor/Vorstandsmitglied -
Sehen Sie sich die Erfahrung von Bob Silverman im Detail an

Ausbildung von Bob Silverman

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

63

Beziehungen ersten Grades

9

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen9

Health Technology

Commercial Services

Consumer Services

Finance

Consumer Services

Finance

Commercial Services

Technology Services

Finance

  1. Börse
  2. Insiders
  3. Bob Silverman